All In Biotech

Free tool

Drugs in development

Investigational drugs and biologics in industry-sponsored Phase 2 and Phase 3 trials that are active or finished in the last two years, and that FDA has not approved. Built from 10,322 ClinicalTrials.gov records, with code names and generic names merged. For approved drugs, use Drug Search.

Last checked: Nov 20, 2026Latest source record: rebuilt Nov 18, 2026Source: ClinicalTrials.govMethods & limitations

Drugs in development

3,685

Not FDA-approved

In Phase 3

1,424

Highest phase reached

Matching your filters

382

Reset

382 drugs in development

Names, sponsors and conditions come from the trial records. Click a drug for its trials.

  • HRS-717Phase 21 trial

    Jiangsu HengRui Medicine Co., Ltd. · Pancreatic Cancer

  • HRS-7172Phase 21 trial

    Jiangsu HengRui Medicine Co., Ltd. · Pancreatic Cancer

  • HRS5580Phase 21 trial

    Fujian Shengdi Pharmaceutical Co., Ltd. · Prevention of Postoperative Nausea and Vomiting

  • HRX215Phase 21 trial

    HepaRegeniX GmbH · Liver Resection, Colorectal Carcinoma Liver Metastases

  • HW201877Phase 21 trial

    Hubei Bio-Pharmaceutical Industrial Technological Institute Inc. · Inflammatory Bowel Disease (IBD)

  • HX009Phase 21 trial

    Hangzhou Hanx Biopharmaceuticals, Ltd. · Biliary Tract Cancer, Melanoma

  • HY-0102Phase 21 trial

    Shanghai YingLi Pharmaceutical Co. Ltd. · Metastatic Pancreatic Cancer

  • ICP-192Phase 21 trial

    Beijing InnoCare Pharma Tech Co., Ltd. · Intrahepatic Cholangiocarcinoma (ICC)

  • IDP-001Phase 21 trial

    InduPro, Inc. · Advanced Solid Tumor, Metastatic Solid Tumor, Head and Neck Squamous Cell Carcinoma

  • IMT-009Phase 21 trial

    Immunitas Therapeutics · Non Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma, Triple Negative Breast Cancer

  • INV-8989Phase 21 trial

    Shenzhen Ionova Life Sciences Co., Ltd. · Advance Solid Tumors, Colon and Rectal Cancer, Non - Small Cell Lung Cancer NSCLC

  • IO-108Phase 21 trial

    Roche (Genentech) · Advanced Liver Cancers

  • IPN01194Phase 21 trial

    Ipsen · Melanoma, Head and Neck Squamous Cell Carcinoma, Pancreatic Ductal Adenocarcinoma

  • IvaltinostatPhase 21 trial

    CG Pharmaceuticals, Inc · Metastatic Pancreatic Adenocarcinoma

  • JMT203Phase 21 trial

    Shanghai JMT-Bio Inc. · Non Small Cell Lung Cancer, Pancreatic Cancer, Cancer Cachexia

  • JYP0015Phase 21 trial

    Guangzhou JOYO Pharma Co., Ltd · Solid Tumor, Pancreatic Ductal Adenocarcinoma (PDAC), Non-small Cell Lung Cancer (NSCLC)

  • KAN-101Phase 21 trial

    Kanyos Bio, Inc., a wholly-owned subsidiary of Anokion SA · Celiac Disease, Coeliac Disease

  • KN713Phase 21 trial

    New Cancer Cure-Bio Co.,Ltd. · Locally Advanced or Metastatic Pancreatic Ductal Adenocarcinoma (PDAC)

  • KQB198Phase 21 trial

    Kumquat Biosciences Inc. · GIST - Gastrointestinal Stromal Tumor, GIST, GIST Metastatic Cancer

  • Kylo 0603Phase 21 trial

    Shanghai Chia Tai Tianqing Pharmaceutical Technology Development Co., Ltd. · Metabolic Dysfunction-Associated Steatoic Liver Disease

  • LG00313112Phase 21 trial

    LG Chem · Ovarian Cancer, Small Cell Lung Cancer, Non Small Cell Lung Cancer

  • LP-184Phase 21 trial

    Lantern Pharma Inc. · Advanced Solid Tumor, Metastatic Solid Tumor, GBM

  • LUM015Phase 21 trial

    Lumicell, Inc. · Colorectal Cancer, Pancreatic Cancer, Esophageal Cancer

  • LY3537021Phase 21 trial

    Eli Lilly · Nausea, Vomiting, Drug-Related Side Effects and Adverse Reactions

  • MDX2001Phase 21 trial

    ModeX Therapeutics, An OPKO Health Company · Biliary Tract Cancer, Breast Cancer, Cervical Cancer

  • MerestinibLY2801653Phase 21 trial

    Eli Lilly · Biliary Tract Cancer, Metastatic Cancer, Advanced Cancer

  • MHS-1031Panosyl-isomaltooligosaccharidePhase 21 trial

    Microbiome Health Sciences · Gastroesophageal Reflux

  • MIV-818Phase 21 trial

    Medivir · Hepatocellular Carcinoma, Intrahepatic Cholangiocarcinoma, Liver Metastases

  • ML-016iNPG-pDoxPhase 21 trial

    BrYet US, Inc. · Advanced Solid Tumor With Lung and/or Liver Involvement

  • MN-001Phase 21 trial

    MediciNova · Diabetes Mellitus, Type 2, Hypertriglyceridemia, Non-Alcoholic Fatty Liver Disease

  • MR001Phase 21 trial

    Shenzhen Majory Biotechnology Co., Ltd. · Pancreatic Ductal Adenocarcinoma (PDAC)

  • MT-201Phase 21 trial

    Mirador Therapeutics, Inc. · Inflammatory Bowel Disease (IBD), Ulcerative Colitis (UC), Crohn's Disease

  • MT-4561Phase 21 trial

    Tanabe Pharma America, Inc. · Head and Neck Squamous Cell Carcinoma (HNSCC), Non-small Cell Lung Cancer (NSCLC), Esophageal Cancer

  • MT-501Phase 21 trial

    Mirador Therapeutics, Inc. · Inflammatory Bowel Disease (IBD), Ulcerative Colitis (UC), Crohn's Disease

  • narmafotinibPhase 21 trial

    Amplia Therapeutics Limited · Pancreatic Cancer Metastatic

  • NDI-101150Phase 21 trial

    Nimbus Saturn, Inc. · Solid Tumor, Renal Cell Carcinoma (Kidney Cancer), Gastric and Gastroesophageal Junction (GEJ) Adenocarcinoma

  • NDX-3315Phase 21 trial

    NexEos Diagnostics, Inc. · Eosinophilic Esophagitis

  • NDX-3324Phase 21 trial

    NexEos Diagnostics, Inc. · Eosinophilic Esophagitis

  • NEO212POH-TMZPhase 21 trial

    Neonc Technologies, Inc. · Diffuse Astrocytoma, IDH-Mutant, Glioblastoma, IDH-wildtype, Brain Metastases, Adult

  • NHS7108Phase 21 trial

    Aimmune Nestlé Health Science US R&D, LLC · Exocrine Pancreatic Insufficiency (EPI), Cystic Fibrosis (CF), Pancreatic Enzyme Abnormality

  • NKT2152Phase 21 trial

    Roche (Genentech) · Advanced Liver Cancers

  • NST-6179Phase 21 trial

    NorthSea Therapeutics B.V. · Intestinal Failure Associated Liver Disease

  • NUV-1511Phase 21 trial

    Nuvation Bio Inc. · Advanced Solid Tumor, HER2-negative Breast Cancer, Metastatic Castration-resistant Prostate Cancer (mCRPC)

  • OPK-88006Phase 21 trial

    OPKO Health, Inc. · MASH

  • PBP1510Phase 21 trial

    Prestige Biopharma Limited · Pancreatic Cancer

  • PEGPH20Phase 21 trial

    Roche (Genentech) · Pancreatic Adenocarcinoma

  • PepinemabPhase 21 trial

    Vaccinex Inc. · Metastatic Pancreatic Adenocarcinoma

  • PM1009Phase 21 trial

    Biotheus Inc. · HCC, Liver Cancer

  • PN20Phase 21 trial

    Chongqing Peg-Bio Biopharm Co., Ltd. · Thrombocytopenia Associated With Chronic Liver Disease

  • Q702Phase 21 trial

    Qurient Co., Ltd. · Esophageal Cancer, Gastric Cancer, Hepatocellular Cancer

NewerPage 7 of 8Older

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.